It would be interesting to do a retrospective anal
Post# of 145351
![](/assets/46931549/no_avatar_available_thumb.jpg)
While the results would be anecdotal and not based on a controlled study, a finding that the Leronlimab treated patients had a significantly lower incidence of Cancers and/or Nash would be blockbuster news. That said, right now the data is available for less than a 1000 patients, but it would be an intriguing analysis.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)